Illumina reagents and consumables to support the NIH labs critical clinical trial experiments.
Ended Awarded Last action
- Contract number
- 75N98026F00004
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $43,508
Award facts
- Contract value 100% obligated
- $43,508.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health awarded a $43,508.16 firm fixed-price delivery order to Illumina, Inc. for reagents and consumables supporting critical clinical trial experiments at NIH laboratories. The delivery order was awarded on February 27, 2026, with an ultimate completion date of March 20, 2026, and carries no set-aside designation. Performance will occur at Illumina's San Diego, California facility. This procurement reflects NIH's reliance on Illumina's specialized genomic sequencing technologies and associated consumables to advance clinical research initiatives across the federal government.
This delivery order likely draws from a larger indefinite delivery contract or blanket purchase agreement established between NIH and Illumina for ongoing reagent and consumable procurement. Illumina, a leading biotechnology company specializing in DNA and RNA sequencing platforms, serves as a prime contractor to multiple federal agencies including the NIH Clinical Center, National Cancer Institute, and other NIH institutes. The company's proprietary sequencing systems and associated consumables are critical infrastructure for contemporary biomedical research, positioning Illumina as a primary technology provider for genomic analysis across the federal research enterprise. The modest contract value and compressed performance timeline suggest this represents a routine task order fulfilling near-term laboratory supply requirements for ongoing clinical investigations.
Quick answers
Who was awarded contract 75N98026F00004?
75N98026F00004 was awarded to Illumina, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on February 27, 2026.
How much is contract 75N98026F00004 worth?
The government has obligated $43,508 on 75N98026F00004.
Is contract 75N98026F00004 an order under another contract?
Yes. 75N98026F00004 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N98026F00004 competed?
The extent of competition for 75N98026F00004 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award